Product Program year 2025 Source: CMS Open Payments

SeptAlign

Device Otolarynology

PDI 00860011696315

Open in the dashboard

General payments

$190,710

290 payments

Research payments

$415,738

19 payments

Through program year 2025, $190,710 in general payments and $415,738 in research payments were reported against SeptAlign (Otolarynology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $131,951 185
2025 Research $415,738 19
2024 General $58,759 105

Breakdown

Who paid General payments · program years 2024–2025
  1. Spirair, Inc. $190,710 290 payments
Top recipients General payments · program year 2025
  1. Jayakar Nayak Otolaryngology · Stanford, CA $22,650 17% · 2 payments
  2. John Gilbert Otolaryngology/Facial Plastic Surgery · Elkhart, IN $15,003 11% · 2 payments
  3. Ryan Neilan Otolaryngology · Shenandoah, TX $11,701 9% · 3 payments
  4. John Davis Otolaryngology · Hoover, AL $9,450 7% · 2 payments
  5. Omar Ahmed Otolaryngology · Houston, TX $9,350 7% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Otolaryngology $111,576 85% · 132 practitioners
  2. Otolaryngology/Facial Plastic Surgery Otolaryngology $16,956 13% · 11 practitioners
  3. Plastic Surgery within the Head & Neck Otolaryngology $960 <1% · 5 practitioners
  4. Otolaryngic Allergy Otolaryngology $608 <1% · 3 practitioners
  5. Physician Assistant $321 <1% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Indiana $35,996 27% · 19 recipients
  2. California $30,205 23% · 5 recipients
  3. Texas $29,992 23% · 44 recipients
  4. Alabama $9,587 7% · 4 recipients
  5. Louisiana $5,585 4% · 14 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

290 general · 19 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record